Skip to content
Open access

AB031. Impact of thymoma on clinical outcomes after thymectomy in patients with myasthenia gravis: a retrospective cohort study

Oct 2026 · Mediastinum · Vol 10 · 0 citations

Abstract

Background Thymectomy is an established treatment for patients with myasthenia gravis (MG), although the influence of thymoma on postoperative clinical improvement remains controversial. This study compared postoperative outcomes between patients with and without thymoma undergoing thymectomy. Methods A retrospective single-center study was conducted based on prospective data collection from the Redcap maintained by the thoracic surgery department in a Brazilian tertiary hospital. Patients with MG (Ach positive), who underwent surgical treatment as an adjuvant to clinical therapy were included. Outcomes included reduction in anticholinesterase medication, corticosteroid reduction, improvement in Myasthenia Gravis Foundation of America (MGFA) clinical class, intensive care unit (ICU) length of stay, and hospital length of stay. Categorical variables were compared using Pearson's chi-square or Fisher's exact test, and continuous variables using the Mann-Whitney U test. Statistical significance was defined as P<0.05 Results The study comprised 85 patients with a mean age of 43 years; 75% were female. Regarding the type of surgery, 24.7% underwent sternotomy and 75.3% minimally invasive approach. Patients with thymoma showed rates of anticholinesterase reduction comparable to those without thymoma (43% vs. 33%, P=0.40). Corticosteroid reduction occurred more frequently in the thymoma group (76% vs. 56%), although this difference did not reach statistical significance (P=0.10). Improvement in MGFA class was observed in all patients with thymoma (100%) compared with 88% of patients without thymoma (P=0.19). Median ICU stay was similar between groups (1 day in both groups; P=0.14), as was median hospital stay (4 days in both groups; P=0.90). Conclusions Patients with and without thymoma experienced comparable clinical improvement following thymectomy. Although patients with thymoma demonstrated numerically greater rates of corticosteroid reduction and universal MGFA class improvement, these differences were not statistically significant. The presence of thymoma did not adversely affect short-term postoperative recovery or overall clinical outcomes, supporting thymectomy as an effective therapeutic strategy for MG regardless of thymoma status.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.